Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to 5.46.

  • Northwest Biotherapeutics' Interest Coverage Ratio rose 2322.0% to 5.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 7.6, marking a year-over-year increase of 2148.84%. This contributed to the annual value of 8.56 for FY2024, which is 1915.02% up from last year.
  • Northwest Biotherapeutics' Interest Coverage Ratio amounted to 5.46 in Q3 2025, which was up 2322.0% from 8.09 recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Interest Coverage Ratio registered a high of 5.46 during Q3 2025, and its lowest value of 15.37 during Q2 2021.
  • Its 5-year average for Interest Coverage Ratio is 10.21, with a median of 10.37 in 2024.
  • As far as peak fluctuations go, Northwest Biotherapeutics' Interest Coverage Ratio tumbled by 11604.7% in 2021, and later skyrocketed by 5226.36% in 2022.
  • Quarter analysis of 5 years shows Northwest Biotherapeutics' Interest Coverage Ratio stood at 9.26 in 2021, then crashed by 60.79% to 14.89 in 2022, then rose by 18.11% to 12.19 in 2023, then skyrocketed by 39.01% to 7.44 in 2024, then increased by 26.52% to 5.46 in 2025.
  • Its Interest Coverage Ratio stands at 5.46 for Q3 2025, versus 8.09 for Q2 2025 and 10.81 for Q1 2025.